Table 2.
Vemurafenib (µM) | Perifosine (µM) | Regorafenib (µM) | Trametinib (nM) | |
---|---|---|---|---|
HROC18 | 8.3 | 15.4 | 1.3 | 39.9 |
HROC24 | 0.8 | 6.7 | 4.6 | 5.1 |
HROC43 | 9.9 | 8.7 | 5.3 | 89.2 |
HROC46 | 12.7 | # | 2.4 | 252 |
#: no inhibitory effects on BrdU incorporation under experimental conditions.